Printer Friendly

Pfizer Japan Obtains Approval for ZYVOX, Detrusitol, J Zoloft in Japan.

Tokyo, Japan, Apr 24, 2006 - (JCN) - Pfizer Japan announced on April 24 that it received approval for an additional indication for ZYVOX Tablets 600mg/ ZYVOX Injection 600mg, its proprietary antibacterial agent, from the Ministry of Health, Labor and Welfare.

ZYVOX is now available for the treatment of infections associated with MRSA (methicillin-resistant Staphylococcus aureus). ZYVOX (linezolid), which has been marketed in Japan since 2001, is currently used in the treatment of infections associated with vancomycin-resistant Enterococcus (VRE).

Pfizer Japan also announced that it received approval for Detrusitol Capsule 2mg/4mg, its proprietary agent for treating overactive bladder (OAB), and J ZOLOFT Tablets 25mg/50mg, its proprietary antidepressant, on the same day.

A selective anticholinergic agent developed by Pfizer of the US, Detrusitol can exert beneficial effects with once-a-day dosage. Initially launched in 1997, the agent is currently prescribed to 10 million patients in about 80 countries worldwide.

J ZOLOFT (sertraline hydrochloride), a selective seretonin reuptke inhibitor developed by Pfizer of the US, is the most prescribed drug for the treatment of depression in the world.

It is estimated that about 12 million people suffer from depression in Japan.

Copyright [c] 2006 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2006 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Geographic Code:9JAPA
Date:Apr 25, 2006
Words:198
Previous Article:Human Growth Hormone Agent Humatrope Now Available for Treatment of Adult Growth Hormone Deficiency.
Next Article:Terumo to Release Medical Support Stockings for Preventing Lymphostasis.
Topics:


Related Articles
Pfizer's Livestock Drug LITTERGUARD LT-C Now Available in Japan.
Sumitomo Chemical Files Suit Against Pfizer for Amlodipine Besilate.
Pfizer Japan Surveys Doctors on Blood Pressure Control.
Pfizer Japan Surveys Children's Drug-taking Behaviors.
Pfizer Introduces OAB Drug Detrusitol to Japan.
Pfizer Japan Obtains Additional Approval for Revolution 6% Parasite Control.
Eli Lilly Japan Obtains Additional Approval for Gemzar Injection.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |